Introduction: Diabetes is associated with abnormalities in lipid profile. The treatment with aspirin may have regulatory effects in lipid profile and accordingly may help in protecting against metabolic abnormalities associated with diabetes.
INTRODUCTION:
Studies have reported increased prevalence of diabetes over time, which confirmed the need of introducing new prevention and appropriate therapies to minimize the occurrence of cardiovascular events among diabetics.The first important approach is to control blood glucose to minimize microvascularchanges related to diabetes. Furthermore, appropriate lipid control is considered crucial to decrease the incidence of cardiovascular events among diabetics [1] [2] [3] [4] .
The study of Al-Nsour and Alkhatib 5 showed that the synthesis of aspirin has begun since 1897. The structure of Aspirin is chemically simple which involves a benzene ring attached to an acetyl group and a carboxylic acid group 6 . Aspirin is called acetylsalicylic acid and it belongs to non-steroidal antiinflammatory drugs (NSAIDs) 7 . Aspirin has been shown to exhibit different therapeutic properties such as analgesic, anti-pyretic, anti-thrombotic and antiinflammatory 8 .
Several studies have proved the efficacy of using aspirin treatment in reducing the incidence of cardiovascular disease (CVD) among high-risk patients who had no preexisting CVD 1-2, 4, 9-12 . Another study indicated that aspirin therapy was able to reduce the risk for coronary heart disease up to 28% 13 .
STUDY OBJECTIVES:
To explore the impact of aspirin treatment on dyslipidemia in diabetic patients who attend outclinics of Jordanian Royal Medical Services.
METHODS AND SUBJECTS:
Study design: This study was based on the retrospective design to collect data from files of diabetic patients.
Study sample: A total of 62 diabetic patients were included.
Data collection:
Data was collected from appropriate files in which the required information is provided.
Study variables include demographic variables such as gender and age; clinical variables related to diabetes such as duration of diabetes, aspirin treatment, and lipid profile. Data were gathered and analyzed using SPSS version 21. Statistical analyses such as descriptive statistics were used. The relationship between study variables was analyzed as required such as Chi-square, and One Way Anova. Significance was examined at alpha <0.05.
RESULTS:

General characteristics of participants
As shown in table 1, the study included 62 diabetic patients. The mean age of participants was 56.95+ 11.98 years. About 53% of participants were males. Duration of diabetes was 7.51+5.86 years. Fifty percent of participants used aspirin; the mean aspirin dose was 111.36+24.67 mg. about 60% of patients had dyslipidemia. The mean level of cholesterol was 217.70+51.58 mg/dl, while the mean level of TG was 246.94+172.40 mg/dl, and that of HDL was 45.89+13.027 mg/dl, and that of LDL was 118.32+41.33 mg/dl. The results of the present study showed that dyslipidemia was associated significantly aspirin dose (p=0.016), cholesterol (p=0.029), and diabetes duration (p=0.05). Accordingly, aspirin has potential therapeutic effects in reducing dyslipidemia and offers protection against possible heart problems associated with diabetes. The importance of these findings comes from the considerations that diabetes has increased prevalence and it is associated with complications such as heart disease [1] [2] [3] [4] .Our findings have confirmed the beneficial effects of aspirin including cardiovascular diseases 1-2, 4, 9-12 . Other beneficial effects included anti-inflammatory properties 8 .
CONCLUSION:
The present study showed a significant relationship between dyslipidemia and aspirin use, diabetes duration, and aspirin dose.
